CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 119 filers reported holding CHEMOCENTRYX INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $930,000 | -87.4% | 100,000 | -81.1% | 0.22% | -88.7% |
| Q1 2019 | $7,364,000 | +298.7% | 530,175 | +213.2% | 1.99% | +195.4% |
| Q4 2018 | $1,847,000 | +272.4% | 169,257 | +102.9% | 0.67% | +140.4% |
| Q4 2017 | $496,000 | +165.2% | 83,428 | +231.3% | 0.28% | +188.7% |
| Q3 2017 | $187,000 | -91.8% | 25,182 | -89.7% | 0.10% | -91.1% |
| Q2 2017 | $2,292,000 | +7.1% | 244,850 | -16.8% | 1.09% | -9.1% |
| Q1 2017 | $2,141,000 | -11.1% | 294,150 | -9.6% | 1.20% | -14.7% |
| Q4 2016 | $2,407,000 | -35.1% | 325,250 | -47.0% | 1.40% | -45.1% |
| Q3 2016 | $3,708,000 | +28.5% | 613,890 | -4.5% | 2.56% | +73.5% |
| Q2 2016 | $2,886,000 | – | 642,828 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |